A new hepatitis B elimination strategy for remote populations is needed.
作者信息
Lee Alice, Hilmers David, Russell Thomas
机构信息
Department of Gastroenterology and Liver Services, Concord Repatriation General Hospital, University of Sydney, Australia.
Department of Internal Medicine and Pediatrics, Center for Space Medicine, Baylor College of Medicine, Houston, TX, USA.
出版信息
Lancet Reg Health West Pac. 2024 Jun 28;48:101129. doi: 10.1016/j.lanwpc.2024.101129. eCollection 2024 Jul.
Abstract
摘要
相似文献
1
A new hepatitis B elimination strategy for remote populations is needed.
Lancet Reg Health West Pac. 2024 Jun 28;48:101129. doi: 10.1016/j.lanwpc.2024.101129. eCollection 2024 Jul.
2
Securing sustainable funding for viral hepatitis elimination plans.
Liver Int. 2020 Feb;40(2):260-270. doi: 10.1111/liv.14282. Epub 2019 Dec 5.
3
Barriers and Strategies for Hepatitis B and C Elimination in Pakistan.
J Infect Dis. 2023 Sep 13;228(Suppl 3):S204-S210. doi: 10.1093/infdis/jiad022.
4
Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.
J Infect Public Health. 2020 Feb;13(2):221-227. doi: 10.1016/j.jiph.2019.08.004. Epub 2019 Aug 21.
5
Training the healthcare workforce to support task-shifting and viral hepatitis elimination: a global review of English language online trainings and in-person workshops for management of hepatitis B and C infection.
BMC Health Serv Res. 2023 Aug 11;23(1):849. doi: 10.1186/s12913-023-09777-x.
6
Global reporting of progress towards elimination of hepatitis B and hepatitis C.
Lancet Gastroenterol Hepatol. 2023 Apr;8(4):332-342. doi: 10.1016/S2468-1253(22)00386-7. Epub 2023 Feb 8.
7
Targeted antiviral treatment of hepatitis B virus in culturally and linguistically diverse populations to achieve elimination targets in Australia.
J Viral Hepat. 2022 Oct;29(10):868-878. doi: 10.1111/jvh.13727. Epub 2022 Jul 2.
8
Preventing early childhood transmission of hepatitis B in remote aboriginal communities in Northern Australia.
Int J Equity Health. 2022 Dec 28;21(1):186. doi: 10.1186/s12939-022-01808-z.
9
Impact and Cost-Effectiveness of Biomedical Interventions on Adult Hepatitis B Elimination in China: A Mathematical Modelling Study.
J Epidemiol Glob Health. 2023 Sep;13(3):517-527. doi: 10.1007/s44197-023-00132-1. Epub 2023 Jun 22.
10
The epidemiology of Hepatitis B, C and D in Germany: A scoping review.
PLoS One. 2020 Mar 9;15(3):e0229166. doi: 10.1371/journal.pone.0229166. eCollection 2020.
引用本文的文献
1
Protektem pikinini blong yu trial: protocol for a single arm field trial to assess the effectiveness of treating-all pregnant women with hepatitis B infection with tenofovir prophylaxis to prevent mother-to-child transmission in Vanuatu, 2024-2025.
BMC Public Health. 2024 Dec 18;24(1):3457. doi: 10.1186/s12889-024-20946-3.
本文引用的文献
1
Global reporting of progress towards elimination of hepatitis B and hepatitis C.
Lancet Gastroenterol Hepatol. 2023 Apr;8(4):332-342. doi: 10.1016/S2468-1253(22)00386-7. Epub 2023 Feb 8.
2
A programme to treat chronic hepatitis B in Kiribati: progress and challenges.
Western Pac Surveill Response J. 2020 Sep 30;11(3):21-25. doi: 10.5365/wpsar.2019.10.4.003. eCollection 2020 Jul-Sep.
3
Towards the elimination of viral hepatitis in Thailand by the year 2030.
J Virus Erad. 2020 Jun 27;6(3):100003. doi: 10.1016/j.jve.2020.100003. eCollection 2020 Sep.
4
Hepatitis B and D in the Pacific Islands of Kiribati.
J Clin Virol. 2020 Aug;129:104527. doi: 10.1016/j.jcv.2020.104527. Epub 2020 Jun 29.
5
Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
BMC Public Health. 2019 Jun 26;19(1):829. doi: 10.1186/s12889-019-7095-4.
6
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
N Engl J Med. 2016 Jun 16;374(24):2324-34. doi: 10.1056/NEJMoa1508660.
Zotero 插件